Machado, Ubiratan Fabres 
; Giannella, Maria Lúcia Cardillo Côrrea
Source: Expert Opinion on Emerging Drugs. Unidades: ICB, FM
Subjects: FISIOLOGIA, GLICOSE, DIABETES MELLITUS, HEMOGLOBINAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Ubiratan Fabres e GIANNELLA, Maria Lúcia Cardillo Côrrea. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis. Expert Opinion on Emerging Drugs, v. 19, n. 1, p. 5-9, 2014Tradução . . Disponível em: https://doi.org/10.1517/14728214.2014.875530. Acesso em: 30 abr. 2024.APA
Machado, U. F., & Giannella, M. L. C. C. (2014). Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis. Expert Opinion on Emerging Drugs, 19( 1), 5-9. doi:10.1517/14728214.2014.875530NLM
Machado UF, Giannella MLCC. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis [Internet]. Expert Opinion on Emerging Drugs. 2014 ; 19( 1): 5-9.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1517/14728214.2014.875530Vancouver
Machado UF, Giannella MLCC. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis [Internet]. Expert Opinion on Emerging Drugs. 2014 ; 19( 1): 5-9.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1517/14728214.2014.875530
